Is the Public Outcry for Johnson & Johnson Jansen’s COVID-19 Vaccine Causing Blood Clots Justified?
Main Article Content
Keywords
FDA, blood clots, vaccine
Abstract
No abstract
Most read articles by the same author(s)
- Sohail Rao, Manish Singh, The Newly Detected B.1.1.529 (Omicron) Variant of SARS-CoV-2 With Multiple Mutations , DHR Proceedings: Vol. 1 No. S5 (2021): Fourth Quarter 2021
- Sohail Rao, MD, FACS, The Should Healthcare Facilities Mandate COVID-19 Vaccination of its Employees? , DHR Proceedings: Vol. 1 No. S4 (2021): Special Publication
- Sohail Rao, Manish Singh, An Evolving Public Health Crisis Caused by the Rapid Spread of the SARS-CoV-2 Delta Variant , DHR Proceedings: Vol. 1 No. S4 (2021): Special Publication
- Sohail Rao, Manish Singh, Will Molnupiravir be the First Oral Treatment for High-Risk Non-Hospitalized Patients with Mild-Moderate COVID-19? , DHR Proceedings: Vol. 1 No. S4 (2021): Special Publication
- Sohail Rao, The Use of Transgenic Mosquitoes to Control Vertical Transmission of Arbovirus-related Illnesses , DHR Proceedings: Vol. 1 No. S3 (2021): Editorial: The Use of Transgenic Mosquitoes to Control Vertical Transmission of Arbovirus-related Illnesses
- Sohail Rao, MD, FACS, Natural vs. Vaccine Mediated COVID-19 Immunity , DHR Proceedings: Vol. 1 No. S4 (2021): Special Publication
- Sohail Rao, Manish Singh, The Rising Incidence of SARS-CoV-2 Infection in the Greater Rio Grande Valley: Is the COVID-19 Pandemic Over? , DHR Proceedings: Vol. 2 No. S3 (2022): Second Quarter Editorial
- Sohail Rao, Manish Singh, Growing Shortage of Healthcare Workers Poses an Existential Threat to the Public Health System , DHR Proceedings: Vol. 1 No. S5 (2021): Fourth Quarter 2021
- Sohail Rao, Alec Vasquez-Kanhere, Manish Singh, Insufficient Scientific Evidence Supporting the Use of Ivermectin in the Prevention and Treatment of COVID-19 , DHR Proceedings: Vol. 1 No. S4 (2021): Special Publication
- Sohail Rao, Manish Singh, Paxlovid Rebound: Proposed Strategy to Prevent Reinfection Following Treatment of COVID-19 Positive Nonhospitalized Patients , DHR Proceedings: Vol. 2 No. S3 (2022): Second Quarter Editorial